Four Canadian universities. Eight researchers. One goal: improve the way therapeutic drugs are delivered in the human body while diversifying the skillset of a new generation of researchers to build on that work in the academic and private sectors.
Two major training grants to the University of Victoria totaling $3.3 million will strengthen research collaboration and train a new generation of skilled researchers for Canada's emerging tech sectors in astronomy instrumentation and drug delivery.
Starting today, warning labels cautioning consumers about the link between alcohol use and an increased risk of breast and colon cancer will be applied to all bottles and cans sold at the Whitehorse liquor store. This specific labelling, part of the study led by UVic’s Canadian Institute for Substance Use Research, is a first for Canada.
A team of engineering researchers from UVic and the University of Rochester has developed a way to detect single molecules using a light-based technology inspired by the “whispering gallery” effect, first discovered in London’s iconic St. Paul’s Cathedral.
A new diagnostic test to determine whether cancer patients should respond well to a specific targeted drug therapy is the goal of a project awarded funding from Genome Canada.
Two University of Victoria biochemists are entering into a collaboration that could take immunotherapy—the latest and most promising form of cancer treatment—to the next level. UVic’s Martin Boulanger and Brad Nelson, a researcher with UVic and the BC Cancer Agency, are partnering with Vancouver-based biotech company Zymeworks Inc. on a cell engineering strategy that will make immunotherapy more potent and precise.
Two University of Victoria biochemists are entering into a collaboration that could take immunotherapy—the latest and most promising form of cancer treatment—to the next level.
A small six-person team of scientists and lab technicians are leading a global revolution in medical diagnostics—from right here, in Victoria. Healthy or not, all of us at some time have been subjected to one of the most common forms of medial diagnostics—the dreaded blood test. But what if there was a way to avoid this uncomfortable process?
A University of Victoria neuroscientist has discovered that a cancer drug may improve recovery rates for diabetic patients who have suffered a stroke.
A newly published study from the University of Victoria’s Centre for Addictions Research of BC (CARBC) confirms that moderate drinkers have an increased risk of breast cancer. The study shows that consuming an average of up to two drinks a day is
Chemistry professor Dr. Frank van Veggel likes to work with extremely small particles and very big ideas. He’s developed a process whereby nanoparticles, each 10 times smaller than a speck of dust, could someday assist oncologists better identify and target cancerous tumours and, in some cases, eliminate the need for painful and potentially dangerous biopsies.
A new process developed at the University of Victoria that will help oncologists better identify and target cancerous tumours has been granted a US patent.
